glp-1 kidney function Glucagon-like Peptide Receptor Agonists and Outcomes in the Era of Personalized Medicine: Focus on Albuminuria Glucagon-Like Peptide-1 Receptor Agonist Use

But their association with women's sports only amplifies the negative effects

This discovery is consistent with the clinical reports (27, 28) on abnormal blood routine and decreased serum iron metabolism indicators in pregnant women with anemia

For people with diabetes taking GLP-1s, kidney function markers like urine albumin-to-creatinine ratio may improve, suggesting kidney protective effects, though the magnitude of benefit is less than with some other diabetes medications like SGLT2 inhibitors

They indicated a shorter coagulation time and an increase in thrombin and fibrin formation [280]

Inoue, K., et al

Its well-tolerated